PHIO

#5181
Phio Pharmaceuticals Corp. - Common Stock
0.0 1 USD
-99.03%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
0.01
0.01
Rango anual
0.01
1.35
Cambio diario
-99.03%
Variación mensual
-99.08%
Variación en los últimos 6 meses
-99.07%
Cambio anual
-99.07%
Cierres anteriores
1.1 4
Open
0.0 1
Mínimo
0.0 1
High
0.0 1
Volumen
5
Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor 202020212022202320242025 TTM

Phio Pharmaceuticals Corp. - Common Stock

Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018.

Noticias